Our program is renowned for our expertise in malignant and non-malignant blood disorders and solid tumors including brain tumors in children, adolescents and young adults. In addition, the members of the Division have provided unique services in the area of treatment of neuroblastoma, lymphomas, and brain tumors. National clinical research protocols have been developed at the University of Michigan for the treatment of refractory neuroblastoma, graft-versus-host-disease, and adaptive cellular therapy of leukemia and lymphoma using stem cell transplantation.
The Division is proud of the achievements in basic research including programsdevoted towards understanding the biology of phagocytosis and generation of myeloid cells. Other research studies are designed to provide novel gene therapeutic approaches for treatment of hemophilia. Other research involves mechanisms of globin switching, pathogenesis of leukemia and neuroblastoma, immune therapy of leukemias, lymphomas, solid tumors, and B-cell signalling.
Our Division currently holds an NIH-supported Hematology Training Grant, which has been awarded to only three programs in the country. Additionally, the Division enjoys the largest continuing support from the National Institutes of Health within the Department of Pediatrics. A number of our faculty members have been recognized over the years by being selected as the Best Doctors in America .
Contact Phone Numbers
General Information: 734-936-9814
Division of Pediatric Hematology/Oncology
1500 East Medical Center Drive
B1-358 CGC Reception B
Ann Arbor, MI 48109-5910